Pharmacist-led continuity of care interventions for patients receiving oral anticancer therapy: a systematic review and meta-analysis
Clicks: 1
ID: 314146
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
0.0
/100
1 views
0 readers
AI Quality Assessment
Not analyzed
Readership in this journal
Ranked #87 of 105 articles by views in International journal for quality in health care : journal of the International Society for Quality in Health Care
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
BACKGROUND: The shift of cancer care to the home setting via oral anticancer therapy has introduced significant challenges to continuity of care and patient safety. Despite its promise, there remains a lack of comprehensive research that characterizes the components of pharmacist interventions and evaluates their impact on clinical outcomes and quality indicators across the continuity of care. METHODS: This review searched PubMed, EMBASE, and Web of Science from inception to December 2024, including studies that implemented pharmacist-led interventions for patients receiving oral anticancer therapy and reported at least one outcome measure in economic, clinical, or humanistic domains. A meta-analysis was conducted using R, calculating the mean difference effect size for continuous outcomes and the odds ratio for dichotomous outcomes. RESULTS: A total of 27 clinical trials evaluating pharmacist-led interventions in patients receiving oral anticancer therapy were identified through systematic searches, including randomized controlled trials, non-randomized controlled trials, and cohort studies. The study identified 11 pharmacist interventions distributed across four main domains, namely patient education and behavioral support, symptom and toxicity management, medication therapy management, and healthcare access support. The meta-analysis revealed that pharmacist interventions tend to improve medication adherence and treatment persistence. However, the impact on objective clinical endpoints and the incidence of drug-related problems remained heterogeneous. Evidence regarding their impact on economic burden, quality of life, and health beliefs and knowledge remains limited. CONCLUSIONS: Pharmacist-led interventions may contribute to quality indicators, specifically treatment adherence and persistence in oral anticancer therapy management. While these improvements are associated with patient safety and treatment effectiveness, current evidence is insufficient to confirm a direct translation into superior clinical endpoints. Further studies are needed to confirm the effectiveness of pharmacist-led interventions in cancer patients and to comprehensively evaluate the value of continuity of care.
| Reference Key |
openalex_W7161737366
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Ting Liu, Xingyu Long, J Y Luo, Q Wang, Jie Xiao, Zhili Wang, Lin Wang, Wang Xie, Ke Sai, Wenhui Zhang, Ping Xu |
| Journal | International journal for quality in health care : journal of the International Society for Quality in Health Care |
| Year | 2026 |
| DOI |
10.1093/intqhc/mzag066
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.